Eurozone | As vaccinations gain speed, upside risk is on the rise
The EU’s vaccine rollout will continue picking up steam in coming months after a lacklustre performance in Q1. Supply constraints have now been largely resolved, thanks to boosted production capacity. Supply is now also well diversified and therefore less susceptible to disruptions. Additionally, improvements in logistics will see further increases in daily vaccination rates.
What you will learn from this report:
- We estimate that the EU countries are well on their way to reaching the target of vaccinating 70% of adults before summer’s end.
- We see risks to our growth outlook for 2021 skewing to the upside on the back of accelerating inoculations, but downside risks remain tangible.
- Infection rates are falling across the EU but remain elevated as the more transmissible variants have taken over, which could delay reopenings. Still, our projections back up our view of gradual reopenings starting in Q2.
Growth outlook determines the fate of fiscal consolidation in APAC
We expect fiscal consolidation to generally continue in Asia, except in mainland China and Taiwan. In those economies, we anticipate looser fiscal policy this year and very slow normalisation next year.Find Out More
Opposition win would secure much-needed EU funding
The Polish parliamentary elections, scheduled for October 15, are likely to be deeply consequential for domestic policy and relations with the EU.Find Out More